Injuries, Wounds and Trauma

NCBiotech Company Directory is a comprehensive listing of North Carolina's life science industry New search

Company Title Company Description City
410 Medical Inc.

410 Medical is developing technology for rapid infusion of fluids for hospital, transport and military healthcare providers, enabling clinicians to quickly and effectively resuscitate critically ill patients.

Adhezion Biomedical LLC

Adhezion Biomedical develops and produces cyanoacrylate-based medical adhesive, wound care and microbial barrier products for connective tissue (human skin). The company's manufacturing and research facility is located in Hudson, N.C.

Agile Sciences Inc.

Agile Sciences is developing a technology for the treatment of antibiotic-resistant, life-threatening infections.

Biocomposites Inc.

Biocomposites develops, manufactures and distributes calcium compound devices to regenerate and repair bone and soft tissue for use in musculoskeletal infections, trauma, spine and sports injuries. The Wilmington office is a sales office.

Carolina Narrow Fabric Co.

Carolina Narrow Fabric manufactures custom-designed, specialty textiles for biomedical and other applications.

Chesson Laboratory Associates Inc.

Chesson Labs develops prescription and over-the-counter polymer-based medical products for wound care and skin and nail care products.

ConvaTec Inc.

ConvaTec develops and manufactures therapies for the management of chronic conditions, with a focus on advanced wound care, ostomy care, continence and critical care and infusion devices. The Triad site is the company's Global Quality Headquarters.

Entegrion Inc.

Entegrion develops biologic and medical device technologies to enhance the safety and availability of the human blood supply. The company also provides blood supply-related contract R&D services to the U.S. Department of Defense.

Gene Facelift LLC

Gene Facelift develops a cosmetic gene therapy in a topical cream formulation to reduce wrinkles, regenerate collagen and restore aging skin. The delivery platform will be used to develop wound healing drugs.

Humacyte Inc.

Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications.

Insoma Bio Inc.

InSomaBio is developing recombinant, protein-based materials to solve problems in tissue engineering and regenerative medicine.

KeraNetics LLC

KeraNetics develops keratin-based biomaterials to be used for wound care and tissue regeneration.

Merakris Therapeutics LLC

Merakris Therapeutics develops biotherapeutic technologies derived from stem cells that promote homeostasis in damaged tissue.

Research Triangle Park
Novan Inc.

Novan develops therapies for dermatological conditions, women's health and gastrointestinal disease using its nitric oxide-releasing technology.

Performance Orthopaedics of the Carolinas Inc.

Performance Orthopaedics of the Carolinas is a distributorship for DePuy Orthopaedics. Performance Orthopaedics sells DePuy's orthopedic devices and supplies.

Plakous Therapeutics LLC

Plakous Therapeutics is developing biotherapeutics from post-delivery placenta to promote regenerative healing for diseases including osteoarthritis, necrotizing enterocolitis, wound healing and tissue engraftment.

Praetego Inc.

Praetego is developing technology to protect against the pathology of oxidative stress. Targets include acute kidney injury (AKI), traumatic brain injury (TBI) and diabetic complications.

Realtromins Inc.

Realtromins has created a family of medical devices for real time risk assessment of critically ill and hospitalized infants and children, providing clinical decision support for healthcare providers.

Chapel Hill
Rilento Pharma LLC

Rilento Pharma is an early stage drug delivery company developing non-addictive oral surgery pain management technologies that are synchronized with the biologic process of wound healing.

Tenax Therapeutics Inc.

Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market.